Search images on Google      Product Monograph

Active Ingredients:

• bortezomib (bortezomib mannitol boronic ester), 3.5 MG/VIAL

DIN: 02485257

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS, SUBCUTANEOUS

Description: SINGLE USE VIAL

Schedule: Prescription

Company: JUNO PHARMACEUTICALS CORP.

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01X - OTHER ANTINEOPLASTIC AGENTS (ATC, WHO)
• L01XG - (ATC, WHO)
• L01XG01 - BORTEZOMIB (WHO)

 

External Links for Bortezomib For Injection:

Search on Google

• Bortezomib For Injection side effects
• Bortezomib For Injection dosage
• bortezomib side effects
• bortezomib dosage